We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLYVA:NASDAQLiberty Live Holdings, Inc. - Series A Liberty Live Group Analysis

Data as of 2026-06-09 - not real-time

$89.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Liberty Live Holdings (LLYVA) trades at $89.65, just above its 200‑day SMA of $88.78 but below the 20‑day ($94.58) and 50‑day ($93.65) averages, indicating short‑term weakness despite a bullish overall trend. The RSI of 39.9 suggests the stock is approaching oversold territory, while a bearish MACD (line –0.70 vs signal 0.13) reinforces downside pressure. Price sits near the identified support level of $87.44 and faces resistance around $99.16. On the fundamentals side, revenue surged 35% YoY to $398.5 M, yet margins remain deeply negative (gross 20%, operating –26%, profit –88%) and the company carries $1.82 B of debt against $524 M of cash, resulting in a negative book value per share. Forward earnings are projected at $1.86 per share, implying a forward P/E of 48.2, far above the industry average of 16.9, while price‑to‑sales stands at 20.7. The Fear & Greed Index at 87.6 (“Extreme Greed”) reflects strong market optimism, but the underlying financials tell a more cautious story.
In summary, the stock is technically near a critical support zone with mixed signals, fundamentally overvalued given its loss profile and debt load, yet it benefits from robust revenue growth and a substantial cash cushion that could support a turnaround if profitability improves.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price testing support at $87.44
  • bearish MACD and sub‑SMA20 price
  • high forward P/E relative to industry

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • 35% revenue growth indicating top‑line momentum
  • projected positive forward EPS
  • substantial cash buffer offsetting debt concerns

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • potential earnings turnaround if margins improve
  • ongoing exposure to discretionary entertainment demand
  • persistent high valuation and negative equity limiting upside

Key Metrics & Analysis

Financial Health

Revenue Growth35.20%
Profit Margin-88.23%
P/E Ratio48.2
ROA-2.05%
P/B Ratio-26.0
Op. Cash Flow$-21615000
Industry P/E16.9

Technical Analysis

TrendBullish
RSI39.9
Support$87.44
Resistance$99.16
MA 20$94.58
MA 50$93.65
MA 200$88.78
MACDBearish
VolumeStable
Fear & Greed Index87.64

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta0.84
Volatility29.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.